CANCELLED - SECTION 8
section 8
on 16 May 2009
Last Applicant/ Owned by
863A MITTEN ROAD
BURLINGAME
CA
94010
Serial Number
75191196 filed on 01st Nov 1996
Registration Number
2194159 registered on 06th Oct 1998
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Logo Mark Trademark Information
formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer
Classification Information
Class [005]
Pharmaceutical Products
formulated nucleic acid pharmaceutical preparations for the treatment of autoimmune diseases, acquired diseases in the nature of coronary artery disease, lung cancer, and melanoma, and genetic diseases in the nature of cystic fibrosis, asthma, breast cancer, and ovarian cancer
First Use Date in General
30th Sep 1996
First Use Date in Commerce
30th Sep 1996
Mark Details
Serial Number
No 75191196
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
19.13.25 -
Other receptacles for laboratory use, including beakers
26.01.01 -
Circles as carriers or as single line borders
26.19.01 -
Spheres
Legal History
| Status Date | Action Taken |
|---|---|
| 16th May 2009 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| 07th Aug 2007 | CASE FILE IN TICRS |
| 27th Oct 2004 | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
| 06th Oct 2004 | REGISTERED - SEC. 8 (6-YR) FILED |
| 06th Oct 2004 | TEAS SECTION 8 RECEIVED |
| 02th Jan 2004 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Oct 1998 | REGISTERED-PRINCIPAL REGISTER |
| 17th Aug 1998 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 15th Jul 1998 | ASSIGNED TO EXAMINER |
| 09th Jul 1998 | STATEMENT OF USE PROCESSING COMPLETE |